🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Upadacitinib sustained-release tablets have not yet been approved for the t...
Status
Active Not Recruiting
Location
Tianjin Eye hospital
Start Date
2025-01-01
Trial ID
NCT07773623
Treatments Being Tested
The primary purpose of this study is to evaluate if the effectiveness of de...
Status
Completed
Location
Beijing Anding Hospital
Start Date
2020-06-18
Trial ID
NCT04364997
Treatments Being Tested
This is a A single-center, randomized, open-label, two-dose, two-period, cr...
Status
Completed
Location
Shanghai Mental Health Center
Start Date
2024-07-31
Trial ID
NCT06474650
Treatments Being Tested
This study was an international, multi-center, randomized, double-blind, pl...
Status
Completed
Location
University of Alabama-Birmingham
Start Date
2006-10
Trial ID
NCT00325442
Treatments Being Tested
This study will determine the maximum tolerated dose (MTD) of arbaclofen pl...
Status
Completed
Location
Research Centers of America
Start Date
2015-09
Trial ID
NCT02511886
Treatments Being Tested
in this trial, we will test the analgesic efficacy of sacral neuromodulatio...
Status
Unknown
Location
Multiple Locations
Start Date
2020-09-10
Trial ID
NCT04549818
Treatments Being Tested
This study aims at evaluating efficacy and safety of topical using Mesalazi...
Status
Withdrawn
Location
Xijing Hospital
Start Date
2016-03
Trial ID
NCT02769494
Treatments Being Tested
The purpose of this study was to evaluate the pharmacokinetic and safety pr...
Status
Completed
Location
Apotex Inc. BioClinical Development
Start Date
2014-05
Trial ID
NCT02189941
Treatments Being Tested
This randomized,active controlled study aimed to compare the effects on sex...
Status
Unknown
Location
The Second Hospital of Lanzhou University
Start Date
2008-04
Trial ID
NCT01238705
Treatments Being Tested
Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersi...
Status
Completed
Location
Bausch Health Site 18
Start Date
2018-09-13
Trial ID
NCT03515044